Note: Ingredients listed on restricted chemical lists
EC/CAS
200-061-5/50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
10.0-
EC/CAS
215-181-3/1310-58-3
Name of the chemical
potassium hydroxide
Concentration
2.0-3.0
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
247-368-0/25956-17-6
Name of the chemical
Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)
Concentration
<0.1
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
<0.1
EC/CAS
223-339-8/3844-45-9
Name of the chemical
Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)
Concentration
<0.01
General Information
Revision date
2018-05-14
Product name
IBUEVANOL PLUS GEL CAPS
Product Synonyms
IBUPROFEN AND CAFFEINE SOFT GEL CAPS * IBUPROFEN AND CAFFEINE, FORMULATED
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
Expected to be non-combustible. Caution - Pharmaceutical agent. See section 11 for additional information on health hazards.
